clinicalRSVP Expands Phase 1 Network, Joins Two California Sites
clinicalRSVP
, the nationwide network that prevents research volunteers from enrolling in multiple concurrent research studies, announced the addition of Anaheim Clinical Trials and Profil Institute for Clinical Research, Inc. to the clinicalRSVP network.
The new California sites will join participating sites in Florida and Ontario who access
clinicalRSVP.com
to check subject eligibility requirements before dosing commences. The addition of the two West Coast sites expands the reach of the clinicalRSVP site network, as well as strengthens the relevance of the network for participating sites. The goal of clinicalRSVP.com is to provide a single continental registry for all Phase 1 investigators to check and report subject eligibility criteria, thereby improving data integrity for sponsors and trial safety for participants.
ClinicalRSVP.com began operating in 2009 with five sites located in South Florida, and has since grown the network to eighteen (18) Phase 1 units across the United States and Canada.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
